Pranlukast hydrate
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161573This classification denotes an anti-asthmatic agent and leukotriene antagonist with the molecular formula 2C27H23N5O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FR702N558K, chemically known as benzamide, n-(4-oxo-2-(2h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-, hydrate (2:1), but more generally known as pranlukast hydrate, which bears US NIH Compound Identifier 5311184. European Medicines Agency schedules pranlukast hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09998MIG. Most nations, for tariff purposes, schedule pranlukast hydrate under HS 29349990. SMILES: C1CCC(CC1)CCCCOC2CCC(CC2)C(=O)NC3CCCC4C3OC(CC4=O)C5[NH]NNN5.C1CCC(CC1)CCCCOC2CCC(CC2)C(=O)NC3CCCC4C3OC(CC4=O)C5[NH]NNN5.O.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.